| abstract |
As used herein, the compound of formula (I) or a pharmaceutically acceptable salt thereof is provided [in the formula, n, R19, R5, R3a, R6a, R6b, R1, R2a, R2b, R4a, R4b, R7a. , R7b, R11a, R11b, R12a, R12b, R17b, R15a, R15b, R16a and R16b are defined herein]. Also provided herein are pharmaceutical compositions comprising a compound of formula (I) and, for example, methods of using the above compounds in the treatment of CNS-related disorders. JPEG2022504607000068.jpg 4662 (I) [Selection diagram] None |